Literature DB >> 30243619

Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.

Jianming Hu1, You-Yu Lin2, Pei-Jer Chen3, Koichi Watashi4, Takaji Wakita5.   

Abstract

Many cell culture and animal models have been used to study hepatitis B virus (HBV) replication and its effects in the liver; these have facilitated development of strategies to control and clear chronic HBV infection. We discuss the advantages and limitations of systems for studying HBV and developing antiviral agents, along with recent advances. New and improved model systems are needed. Cell culture systems should be convenient, support efficient HBV infection, and reproduce responses of hepatocytes in the human body. We also need animals that are fully permissive to HBV infection, convenient for study, and recapitulate human immune responses to HBV and effects in the liver. High-throughput screening technologies could facilitate drug development based on findings from cell and animal models.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immune Response; Mouse; Treatment; Viral Infection

Mesh:

Year:  2018        PMID: 30243619      PMCID: PMC6649672          DOI: 10.1053/j.gastro.2018.06.093

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

1.  Host cell-dependent late entry step as determinant of hepatitis B virus infection.

Authors:  Xupeng Hong; Yuka Imamura Kawasawa; Stephan Menne; Jianming Hu
Journal:  PLoS Pathog       Date:  2022-06-17       Impact factor: 7.464

Review 2.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 3.  Regulation and functional roles of chemokines in liver diseases.

Authors:  Sheng Cao; Mengfei Liu; Tejasav S Sehrawat; Vijay H Shah
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-11       Impact factor: 73.082

4.  Characterization and Application of Precore/Core-Related Antigens in Animal Models of Hepatitis B Virus Infection.

Authors:  Xupeng Hong; Laurie Luckenbaugh; David Perlman; Peter A Revill; Stefan F Wieland; Stephan Menne; Jianming Hu
Journal:  Hepatology       Date:  2021-07       Impact factor: 17.298

5.  Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.

Authors:  Tanvir Hossain; Shahla Romal; Elisa De Crignis; Fabrizia Carofiglio; Panagiotis Moulos; Mir Mubashir Khalid; Shringar Rao; Ameneh Bazrafshan; Monique Ma Verstegen; Farzin Pourfarzad; Christina Koutsothanassis; Helmuth Gehart; Tsung Wai Kan; Robert-Jan Palstra; Charles Boucher; Jan Nm IJzermans; Meritxell Huch; Sylvia F Boj; Robert Vries; Hans Clevers; Luc Jw van der Laan; Pantelis Hatzis; Tokameh Mahmoudi
Journal:  Elife       Date:  2021-07-30       Impact factor: 8.140

Review 6.  The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development.

Authors:  Zhengying Zhou; Jinwei Zhu; Muhan Jiang; Lan Sang; Kun Hao; Hua He
Journal:  Pharmaceutics       Date:  2021-05-12       Impact factor: 6.321

Review 7.  Bile Goes Viral.

Authors:  Victoria R Tenge; Kosuke Murakami; Wilhelm Salmen; Shih-Ching Lin; Sue E Crawford; Frederick H Neill; B V Venkataram Prasad; Robert L Atmar; Mary K Estes
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

8.  Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells.

Authors:  Xinlei Li; Zhaohui Xu; Bidisha Mitra; Minghang Wang; Haitao Guo; Zongdi Feng
Journal:  Cell Biosci       Date:  2021-07-05       Impact factor: 7.133

Review 9.  Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.

Authors:  Laura A Novotny; John Grayson Evans; Lishan Su; Haitao Guo; Eric G Meissner
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

10.  A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals.

Authors:  Jaewon Yang; Alexander König; Soonju Park; Eunji Jo; Pil Soo Sung; Seung Kew Yoon; Eva Zusinaite; Denis Kainov; David Shum; Marc Peter Windisch
Journal:  JHEP Rep       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.